Wang Cheng-Ping, Yu Kelly J, Chen Tseng-Cheng, Tsai Ming-Shui, Kang Chung-Jan, Chien Chi-Yen, Engels Eric A, Hua Chun-Hung, Hsu Wan-Lun, Chang Yih-Leong, Dawsey Sanford M, Wentzensen Nicolas, Shi Jianxin, Mao Fangya, Cheung Li C, Katki Hormuzd A, Boyd Eric, Wu Chen-Tu, Gutkind J Silvio, Molinolo Alfredo, Limbach Abberly-Lott, Lingen Mark W, Lou Pei-Jen, Chen Chien-Jen, Hildesheim Allan, Chaturvedi Anil K
National Taiwan University Hospital and College of Medicine Taiwan.
Division of Cancer Epidemiology and Genetics, National Cancer Institute Rockville MD USA.
Oral Oncol. 2025 Mar;162:107210. doi: 10.1016/j.oraloncology.2025.107210. Epub 2025 Feb 12.
To characterize multistate oral carcinogenesis, we conducted a cohort study of patients with oral precancer and a parallel case-control study of oral cancers and controls in Taiwan.
During 2013-2019, we recruited patients with oral precancer (n = 1998) or invasive oral cancer (n = 768) and hospital-based controls (n = 717). Precancer patients were followed up biannually for up to five years; questionnaire data and biospecimens were collected at multiple timepoints. Precancer natural history (regression/persistence, incidence, progression) was evaluated through follow-up visits and linkages with Taiwan's Cancer Registry.
Cross-sectionally, 71 % of oral precancers and 62 % of cancers were attributable to betel-quid chewing, smoking, and alcohol. Precancer patients had substantially elevated risk of oral cancer (standardized-incidence-ratio vs. Taiwan general population = 14.1; 95 %CI = 12.0-16.6). Among precancer patients, 156 incident invasive oral cancers occurred (median follow-up = 6.4 years; incidence rate = 1,221/100,000 person-years; annual incidence = 1.2 %; 1-year cumulative-incidence = 1.8 %; 5-year cumulative-incidence = 6.9 %; 10-year cumulative-incidence = 9.5 %). Baseline precancer histopathology strongly predicted risk of progression to oral cancer (5-year cumulative-incidence: no-dysplasia = 5.2 %, mild-dysplasia = 7.1 %, moderate-dysplasia = 32.8 %, severe-dysplasia = 45.9 %). Most oral cancers (88.5 %) were preceded by precancers identified during the study. The study has established a resource of >63,500 biospecimens, including biopsies (n = 6,012), oral cytology (n = 18,422), oral rinses (n = 15,054), saliva (n = 15,066), and blood (n = 8,990). Ongoing investigations are characterizing oral carcinogenesis at the epidemiologic, macroscopic, microscopic, microbiomic, and genomic levels.
A majority of oral precancers/cancers in Taiwan are caused by betel-quid chewing, smoking, and alcohol. Patients with oral precancer have substantially elevated risk of site-concordant oral cancer. We highlight our study as a resource to collaboratively address questions regarding oral precancer/cancer natural history and clinical management.
为了描述多阶段口腔癌发生过程,我们在台湾对口腔癌前病变患者进行了一项队列研究,并对口腔癌患者及对照进行了一项平行病例对照研究。
在2013年至2019年期间,我们招募了口腔癌前病变患者(n = 1998)、浸润性口腔癌患者(n = 768)以及以医院为基础的对照(n = 717)。对癌前病变患者每半年随访一次,为期五年;在多个时间点收集问卷数据和生物标本。通过随访以及与台湾癌症登记处的关联,评估癌前病变的自然史(消退/持续、发病率、进展情况)。
从横断面来看,71%的口腔癌前病变和62%的癌症可归因于嚼槟榔、吸烟和饮酒。癌前病变患者患口腔癌的风险大幅升高(标准化发病率比与台湾普通人群相比 = 14.1;95%置信区间 = 12.0 - 16.6)。在癌前病变患者中,发生了156例浸润性口腔癌(中位随访时间 = 6.4年;发病率 = 1221/100,000人年;年发病率 = 1.2%;1年累积发病率 = 1.8%;5年累积发病率 = 6.9%;10年累积发病率 = 9.5%)。基线癌前病变组织病理学强烈预测了进展为口腔癌的风险(5年累积发病率:无发育异常 = 5.2%,轻度发育异常 = 7.1%,中度发育异常 = 32.8%,重度发育异常 = 45.9%)。大多数口腔癌(88.5%)之前在研究期间已被识别出存在癌前病变。该研究已建立了超过63,500份生物标本的资源库,包括活检标本(n = 6012)、口腔细胞学标本(n = 18422)、口腔冲洗液标本(n = 15054)、唾液标本(n = 15066)和血液标本(n = 8990)。正在进行的调查在流行病学、宏观、微观、微生物组和基因组水平上描述口腔癌发生过程。
台湾地区大多数口腔癌前病变/癌症是由嚼槟榔、吸烟和饮酒引起的。口腔癌前病变患者患部位一致的口腔癌的风险大幅升高。我们强调本研究可作为一种资源,用于合作解决有关口腔癌前病变/癌症自然史和临床管理的问题。